TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
NCT00694629
Actinomycetales Infections, Bacterial Infections
Little Rock, Arkansas, United States
View Trial DetailsNCT Number: NCT01379066
The Pulmonary Colonization Test is a non-invasive breath test for markers of lower respiratory tract infection, which may predict the probability of mycobacterial organisms in the lower respiratory tract. It consists of:
* A breath collection apparatus for collection of volatile organic compounds in breath onto a sorbent trap and Tedlar bag, as well as for the collection of a separate sample of room air. * Analysis of the volatile organic compounds in breath and room air by short acoustic wave/gas chromatography. * Interpretation of the volatile organic compounds with a proprietary algorithm in order to predict the probability of lower respiratory tract colonization and infection. * Analysis of the volatile organic compounds in sputum culture by short acoustic wave/gas chromatography.
This study will test the hypothesis that the investigators can identify the presence of mycobacteria in an individual by sampling the breath of patients with active tuberculosis and by sampling "head space" above culture media of sputum provided. This study will test the hypotheses:
* that the investigators can identify positive cultures for mycobacterium tuberculosis through sampling of the headspace above the cultures prior to standard laboratory culture identification * that the investigators can identify control of tuberculosis by sampling exhaled breath
Looking for future studies?
Notify Me1 year–40 year
All sexes
Observational
Oxnard Specialty Clinic, Oxnard, California, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Tuberculosis will be identified form culture plates by the volatile organic compound signature
Landon Pediatric Foundation
Other
Detection of Mycobacteria in Lungs and Culture Using an Ultra-fast Gas Chromatograph
Acronym: TBVOC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00694629
Actinomycetales Infections, Bacterial Infections
Little Rock, Arkansas, United States
View Trial DetailsNCT07595588
Actinomycetales Infections, Bacterial Infections
Hong Kong
View Trial DetailsNCT04930744
Actinomycetales Infections, Bacterial Infections
Johannesburg, Gauteng, South Africa
View Trial DetailsNCT04666311
Abnormalities, Multiple, Actinomycetales Infections
Butha-Buthe, Lesotho
View Trial Details